{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:25:32Z","timestamp":1791044732386,"version":"4.1.0"},"reference-count":46,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Thrombotic microangiopathy (TMA) is a category of diseases consisting of thrombocytopenia, microangiopathic haemolytic anaemia, and widespread occlusive microvascular thrombosis. We report two cases of a thrombotic microangiopathic syndrome associated with non-invasive mucinous cysts and mucinous adenocarcinoma. TMA was treated in both cases by surgical removal of the tumours. We hypothesise that mucin secretion in the case of non-invasive mucinous cysts and paraneoplastic secretion of antibodies in the case of mucinous adenocarcinomas are the causes of endothelial damage with thrombocytopenia and microangiopathic haemolytic anaemia. Finally, patients with TMA who exhibit unusual clinical characteristics or weak responses to plasma exchange should be examined for an underlying tumour. Tumour treatment is the preferred therapy for tumour-associated TMA.<\/jats:p>","DOI":"10.3390\/jcm14072164","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T06:21:38Z","timestamp":1742797298000},"page":"2164","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumour-Associated Microangiopathic Haemolytic Anaemia with Thrombocytopenia: A Narrative Review and Case Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9854-2611","authenticated-orcid":false,"given":"Vedran","family":"Kovacic","sequence":"first","affiliation":[{"name":"Internal Medicine Department, Division of Internistic Intensive Medicine with Clinical Pharmacology and Toxicology, University Hospital of Split, School of Medicine, University of Split, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijana","family":"Mikacic","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Division of Internistic Intensive Medicine with Clinical Pharmacology and Toxicology, University Hospital of Split, School of Medicine, University of Split, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7921-8218","authenticated-orcid":false,"given":"Ivan","family":"Jerkovic","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Division of Internistic Intensive Medicine with Clinical Pharmacology and Toxicology, University Hospital of Split, School of Medicine, University of Split, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Ilic Begovic","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Division of Internistic Intensive Medicine with Clinical Pharmacology and Toxicology, University Hospital of Split, School of Medicine, University of Split, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Maras","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Division of Internistic Intensive Medicine with Clinical Pharmacology and Toxicology, University Hospital of Split, School of Medicine, University of Split, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N. Eng. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1542\/pir.22-11-365","article-title":"Hemolytic-uremic syndrome","volume":"22","author":"Corrigan","year":"2001","journal-title":"Pediatr. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1365-2141.2000.01941.x","article-title":"Management of thrombotic thrombocytopenic purpura","volume":"109","author":"Rock","year":"2000","journal-title":"Br. J. Haematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00005792-197909000-00004","article-title":"Microangiopathic hemolytic anemia and cancer: A review","volume":"58","author":"Antman","year":"1979","journal-title":"Medicine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2003-01-0193","article-title":"ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients","volume":"102","author":"Vesely","year":"2003","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1756-8722-1-23","article-title":"Thrombotic thrombocytopenic purpura hemolytic uremic syndrome (TTP-HUS): A 24-year clinical experience with 178 patients","volume":"1","author":"Levandovsky","year":"2008","journal-title":"J. Hematol. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1634\/theoncologist.12-1-11","article-title":"Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases","volume":"12","author":"Francis","year":"2007","journal-title":"Oncologist"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1523-1755.2001.060003831.x","article-title":"Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura","volume":"60","author":"Ruggenenti","year":"2001","journal-title":"Kidney Int."},{"key":"ref_9","first-page":"627","article-title":"The role of ADAMTS 13 in the pathogenesis of thrombocytopenic purpura-hemolytic uremic syndrome","volume":"3","author":"George","year":"2005","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1182\/blood-2002-02-0344","article-title":"Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: A severely deficient activity is specific for thrombotic thrombocytopenic purpura","volume":"100","author":"Bianchi","year":"2002","journal-title":"Blood"},{"key":"ref_11","first-page":"649","article-title":"Cancer-associated thrombotic microangiopathy","volume":"10","author":"Bhat","year":"2016","journal-title":"Ecancermedicalscience"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MD.0b013e3182603598","article-title":"Cancer-related microangiopathic hemolytic anemia: Clinical and laboratory features in 168 reported cases","volume":"91","author":"Lechner","year":"2012","journal-title":"Medicine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1634\/theoncologist.8-4-375","article-title":"Thrombotic thrombocytopenic purpura associated with bone marrow metastasis and secondary myelofibrosis in cancer","volume":"8","author":"Chang","year":"2003","journal-title":"Oncologist"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1445-5994.1999.tb00730.x","article-title":"Haemolytic uraemic syndrome and prostatic cancer","volume":"29","author":"Perkovic","year":"1999","journal-title":"Aust. N. Z. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1055\/s-2005-858259","article-title":"Microangiopathic hemolytic anemia (MAHA) as paraneoplastic syndrome in metastasized signet ring cell carcinomas: Case reports and review of the literature","volume":"43","author":"Arkenau","year":"2005","journal-title":"Z. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1634\/theoncologist.10-4-299","article-title":"Thrombotic thrombocytopenic purpura secondary to an occult adenocarcinoma","volume":"10","author":"Pirrotta","year":"2005","journal-title":"Oncologist"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00000421-200002000-00021","article-title":"Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breast","volume":"23","author":"Sandherr","year":"2000","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1186\/s40064-016-2312-4","article-title":"Microangiopathic hemolytic anemia associated with metastatic breast cancer: Case report and literature review","volume":"5","author":"Takabatake","year":"2016","journal-title":"SpringerPlus"},{"key":"ref_19","first-page":"368","article-title":"Microangiopathic hemolytic anemia in metastatic carcinoma","volume":"79","author":"Lohrmann","year":"1973","journal-title":"Rep. Eight Cases Ann. Intern. Med."},{"key":"ref_20","first-page":"161","article-title":"Fatal thrombotic thrombocytopenic purpura (TTP) presenting concurrently with metastatic endocrine neoplasia (MEN) type I","volume":"10","author":"Kouides","year":"1996","journal-title":"Hematop. Mol. Hematol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000069291","article-title":"Presence of ADAMST13 activity in a patient with metastatic cancer and thrombotic microangiopathy","volume":"109","author":"Forman","year":"2003","journal-title":"Acta Haematol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/annonc\/mdn160","article-title":"Purpura in a patient with disseminated breast cancer:a rapidly progressive cancer-related thromboticthrombocytopenic purpura","volume":"19","author":"Spoormans","year":"2008","journal-title":"Ann. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4065\/77.4.323","article-title":"Chronic thrombotic microangiopathy associated with antineoplastic therapy with minimal hematologic effects","volume":"77","author":"Raife","year":"2002","journal-title":"Mayo Clin. Proc."},{"key":"ref_24","first-page":"ECR01","article-title":"Thrombotic thrombocytopenic purpura and bone marrow necrosis as a complication of gastric neoplasm","volume":"87","author":"Gonzalez","year":"2002","journal-title":"Haematologica"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/1076029607303346","article-title":"Thrombotic thrombocytopenic purpura and bone marrow necrosis as the initial presentation of lung cancer","volume":"13","author":"Sevinc","year":"2007","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/jjco\/hyh082","article-title":"A case of bone marrow necrosis with thrombotic thrombocytopenic purpura as a manifestation of occult colon cancer","volume":"34","author":"Lee","year":"2004","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/(SICI)1097-0142(20000415)88:8<1769::AID-CNCR3>3.0.CO;2-H","article-title":"Bone marrow necrosis","volume":"88","author":"Janssens","year":"2000","journal-title":"Cancer"},{"key":"ref_28","first-page":"301","article-title":"Coagulation and cancer: Implications for diagnosis and management Pathol","volume":"6","author":"Loreto","year":"2000","journal-title":"Oncol. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/1097-0142(197510)36:4<1473::AID-CNCR2820360440>3.0.CO;2-D","article-title":"Microscopic pulmonary tumor emboli associated with dyspnea","volume":"36","author":"Kane","year":"1975","journal-title":"Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1200\/JCO.2011.36.7433","article-title":"Thrombotic microangiopathy and disseminated intravascular coagulation associated with carcinocythemia in a patient with breast cancer","volume":"29","author":"Robier","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1200\/JOP.2016.012096","article-title":"Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer","volume":"12","author":"Morton","year":"2016","journal-title":"J. Oncol. Pract."},{"key":"ref_32","first-page":"908","article-title":"Systemic malignancies as a cause of unexpected microangiopathic hemolytic anemia and thrombocytopenia","volume":"25","author":"George","year":"2011","journal-title":"Oncology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/bcp.13808","article-title":"Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort","volume":"85","author":"Daviet","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1365-2141.2001.02704.x","article-title":"Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease","volume":"113","author":"Fontana","year":"2001","journal-title":"Br. J. Haematol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2141.1970.tb01433.x","article-title":"Microangiopathic haemolytic anaemia and mucin forming adenocarcinoma","volume":"18","author":"Brain","year":"1970","journal-title":"Br. J. Haematol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajh.10366","article-title":"Thrombotic thrombocytopenic purpura associated with a prolactin-producing pituitary adenoma","volume":"74","author":"Kovacs","year":"2003","journal-title":"Am. J. Hematol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V98.9.2730","article-title":"Changes in health and disease of the metalloprotease that cleaves von Willebrand factor","volume":"98","author":"Mannucci","year":"2001","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/pgmj.58.680.362","article-title":"Microangiopathic haemolytic anaemia associated with recurrent pulmonary emboli and benign pelvic tumours","volume":"58","author":"Blau","year":"1982","journal-title":"Postgrad. Med. J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e2012030","DOI":"10.4084\/mjhid.2012.030","article-title":"Microangiopathic Hemolytic Anemia in 57-year old Woman with Borderline Serous Tumor of the Ovary: Real Time Management of Common Pathways of Hemostatic Failure","volume":"4","author":"Morris","year":"2012","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1182\/blood.V96.4.1223","article-title":"How I treat patients with thrombotic thrombocytopenic purpura\u2013hemolytic uremic syndrome","volume":"96","author":"George","year":"2000","journal-title":"Blood"},{"key":"ref_41","first-page":"295","article-title":"Management of cancer accociated thrombotic microangiopathy: What is the right approach?","volume":"81","author":"Werner","year":"2006","journal-title":"Am. J. Hematol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000494753","article-title":"Hemolytic Anemia of Malignancy: A Case Study Involving Signet Ring Cell Metastatic Breast Cancer with Severe Microangiopathic Hemolytic Anemia","volume":"12","author":"Lee","year":"2019","journal-title":"Case Rep. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.21873\/invivo.12452","article-title":"Thrombotic Microangiopathy: A Rare Breast Cancer-associated Complication Treated Successfully With Doxorubicin and Cyclophosphamide","volume":"35","author":"Jalali","year":"2021","journal-title":"In Vivo"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1046\/j.1537-2995.2002.00260.x","article-title":"Platelet transfusion and thrombotic thrombocytopenic purpura","volume":"42","author":"Arriaga","year":"2002","journal-title":"Transfusion"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1111\/trf.12917","article-title":"Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome","volume":"54","author":"McClain","year":"2014","journal-title":"Transfusion"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1634\/theoncologist.2009-0067","article-title":"Reference Center for the Management of Thrombotic Microangiopathies. Cancer awareness in atypical thrombotic microangiopathies","volume":"14","author":"Oberic","year":"2009","journal-title":"Oncologist"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/7\/2164\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:58:18Z","timestamp":1760029098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/7\/2164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["jcm14072164"],"URL":"https:\/\/doi.org\/10.3390\/jcm14072164","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,22]]}}}